Department of Anaesthesia, Glasgow Royal Infirmary, 91 Wishart Street, Glasgow, Scotland G31 2HT, UK.
Trials. 2013 Aug 19;14:263. doi: 10.1186/1745-6215-14-263.
An arteriovenous fistula is the optimal form of vascular access in patients with end-stage renal failure requiring haemodialysis. Unfortunately, approximately one-third of fistulae fail at an early stage. Different anaesthetic techniques can influence factors associated with fistula success, such as intraoperative blood flow and venous diameter. A regional anaesthetic brachial plexus block results in vasodilatation and improved short- and long-term fistula flow compared to the infiltration of local anaesthetic alone. This, however, has not yet been shown in a large trial to influence long-term fistula patency, the ultimate clinical measure of success.The aim of this study is to compare whether a regional anaesthetic block, compared to local anaesthetic infiltration, can improve long-term fistula patency.
This study is an observer-blinded, randomised controlled trial. Patients scheduled to undergo creation of either brachial or radial arteriovenous fistulae will receive a study information sheet, and consent will be obtained in keeping with the Declaration of Helsinki. Patients will be randomised to receive either: (i) an ultrasound guided brachial plexus block using lignocaine with adrenaline and levobupivicaine, or (ii) local anaesthetic infiltration with lignocaine and levobupivicaine.A total of 126 patients will be recruited. The primary outcome is fistula primary patency at three months. Secondary outcomes include primary patency at 1 and 12 months, secondary patency and fistula flow at 1, 3 and 12 months, flow on first haemodialysis, procedural pain, patient satisfaction, change in cephalic vein diameter pre- and post-anaesthetic, change in radial or brachial artery flow pre- and post-anaesthetic, alteration of the surgical plan after anaesthesia as guided by vascular mapping with ultrasound, and fistula infection requiring antibiotics.
No large randomised controlled trial has examined the influence of brachial plexus block compared with local anaesthetic infiltration on the long-term patency of arteriovenous fistulae. If the performance of brachial plexus block increases fistulae patency, this will have significant clinical and financial benefits as the number of patients able to commence haemodialysis when planned should increase, and the number of "redo" or revision procedures should be reduced.
This study has been approved by the West of Scotland Research Ethics Committee 5 (reference no. 12/WS/0199) and is registered with the ClinicalTrials.gov database (reference no. NCT01706354).
动静脉瘘是终末期肾衰竭需要血液透析患者的最佳血管通路形式。不幸的是,大约三分之一的瘘管在早期失败。不同的麻醉技术可以影响瘘管成功的相关因素,如术中血流量和静脉直径。与单独局部麻醉浸润相比,臂丛神经阻滞导致血管扩张,并改善短期和长期瘘管流量。然而,这尚未在大型试验中表明可以影响长期瘘管通畅率,这是成功的最终临床衡量标准。本研究的目的是比较臂丛神经阻滞与局部麻醉浸润是否可以提高长期瘘管通畅率。
这是一项观察者盲法、随机对照试验。计划行肱动脉或桡动脉动静脉瘘管成形术的患者将收到研究信息表,并按照《赫尔辛基宣言》获得同意。患者将随机分为以下两组:(i)接受利多卡因加肾上腺素和左旋布比卡因的超声引导下臂丛神经阻滞,或(ii)接受利多卡因和左旋布比卡因的局部麻醉浸润。总共将招募 126 名患者。主要结局是三个月时瘘管初次通畅率。次要结局包括 1 个月和 12 个月时的初次通畅率、继发性通畅率和瘘管流量,1、3 和 12 个月时的流量,首次血液透析时的流量,手术疼痛程度,患者满意度,麻醉前和麻醉后头静脉直径的变化,麻醉前和麻醉后桡动脉或肱动脉流量的变化,根据血管超声图进行血管定位后改变手术计划,以及需要抗生素治疗的瘘管感染。
尚无大型随机对照试验研究过臂丛神经阻滞与局部麻醉浸润对动静脉瘘长期通畅率的影响。如果臂丛神经阻滞能提高瘘管通畅率,这将具有重要的临床和经济效益,因为计划开始血液透析的患者数量应该增加,而“重新”或修订手术的数量应该减少。
该研究已获得西苏格兰研究伦理委员会 5 号(注册号:12/WS/0199)的批准,并在 ClinicalTrials.gov 数据库中注册(注册号:NCT01706354)。